• <acronym id="67raz"></acronym>
    1. <span id="67raz"><output id="67raz"><b id="67raz"></b></output></span>
      <ol id="67raz"><output id="67raz"></output></ol>
    2. <acronym id="67raz"></acronym>

      Company History

      Your current location:首頁 > About Lonzeal > Company History

      2006 Lonzeal Pharmaceuticals was established

      2008 The production base of Lonzeal Pharmaceuticals was put into operation

      2010 Obtained the GMP certificate of raw materials from the State Food and Drug Administration of China

      2012 Passed the GMP on-site inspection of the World Health Organization

      From 2012 to 2015, API products have been registered in Brazil, Russia, South Africa and other countries

      2017 Passed the GMP on-site inspection of multiple anti-AIDS APIs by the World Health Organization

      2018 Zero defect passed the US FDA's API GMP on-site inspection

      2019 Anti-AIDS and hepatitis B preparation products took the lead in passing the consistency evaluation

      2021 Paroxetine Hydrochloride, Tenofovir Alafenamide Fumarate, and Pregabalin passed the consistency evaluation and obtained drug registration approval

      About Lonzeal

      Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.

      Domestic sales center:17703115689    liuyu@lonzeal.com
      International Sales Center:15931139631    emma@lonzeal.com
      Human Resource Center:0311-87512081    lzzyhr@lonzeal.com
      Address: Shenze County Industrial Park, Shijiazhuang City, Hebei Province (No. 16 West Ring Road)

      WeChat qr code
      Copyright:Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.   冀ICP備09039052號-1